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James E ClarkAbstract
There are number of means of methods to alter body composition, and metabolic issues, available for the adult
who is overfat. The following is a systematic review and meta-analysis focused on comparing changes from
treatment program for adults who are overfat based on analysis of aggregated effect size (ES) of inducing changes.
So as to determine the relative effectiveness of such protocols and intervention plans of choice. This tiered
meta-analysis of 66-population based studies, and 162-studywise groups, a clear pattern of ES being established
across and within treatments. First, hypocaloric balance is necessary for changing body composition, but the
effectiveness for establishing imbalance does not equate with the effectiveness for body compositional changes, or
any biomarkers associated with metabolic issues. With analysis showing that there is a necessity to include exercise
in combination with diet effectively elicit changes in body composition and biomarkers of metabolic issues. More
importantly, the combination, resistance training (RT) was more effective than endurance training (ET) or
combination of RT and ET, particularly when progressive training volume of 2-to-3 sets for 6-to-10 reps at an
intensity of ≥75% 1RM, utilizing whole body and free-weight exercises, at altering body compositional measures
(ES of 0.47, 0.30, and 0.40 for loss of BM, FM, and retention of FFM respectively) and reducing total cholesterol
(ES = 0.85), triglycerides (ES = 0.86) and low-density lipoproteins (ES = 0.60). Additionally RT was more effective at
reducing fasting insulin levels (ES = 3.5) than ET or ET and RT. Even though generally lower ES than RT, the inclusion
of ET was more effective when performed at high intensity (e.g. ≥70% VO2max or HRmax for 30-minutes 3-4x’s/wk),
or in an interval training style than when utilizing the relatively common prescribed method of low-to-moderate
(e.g., 50-70% VO2max or HRmax for at least equal time) steady state method, ES of 0.35, 0.39, and 0.13 for BM, FM,
and FFM respectively. Thus indicating that focus of treatment should be on producing a large metabolic stress
(as induced by RT or high levels of ET) rather than an energetic imbalance for adults who are overfat.
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Accompanying the epidemic rise in the rate of obesity
and obesity related diseases over the past half-century
there has also been a rise in a variety of therapeutic in-
terventions to address this epidemic. Most notable amongst
these interventions have been numerous protocols that at-
tempt to change body composition, most often through
total mass reduction (i.e. weight loss). Resulting not only in
a multibillion-dollar industry, but a greater absolute num-
ber of US adults currently engaging in behaviors (e.g., hypo-
caloric dieting, or involvement of general exercise and
physical activity), with the focus based on the implication
that all mass as being equal in the equation of body mass,
obesity and disease [1-3]. To support such a position, sev-
eral authors [4-9] have previously noted that there are lim-
ited differences in results for absolute changes in body
composition with comparison between the various method-
ologies employed for treatment of weight issues for an indi-
vidual who is overfat. While others [4,9-12] have indicated
the responses are more related to an energetic imbalance
(e.g., kcal/day, kJ/day) between dietary caloric load and ex-
penditure from activity that results from the intervention of
choice (e.g., diet, exercise, or combination therein) than the
actual intervention for the adult who is overfat.
However, the discussion of effective outcome must go
beyond any reduction in body mass or even health fac-
tors. Instead, the overall outcome has to involve a large
change in self-selected and self-motivated behaviors. A
change that serves to increase health and fitness behav-
iors and invoke a psychological adherence to exercise
that most adults who are overfat might not intrinsically
possess. Something that has become evident in the low
attrition rates within many exercise programs and the
high rate of repeated hypocaloric diet attempts [13-16].
Yet many of the marketing verbiage, seen through any
scan of popular media, of intervention programs lead to
the idea of adherence to any program appears related to
the ability for that program to alter body mass. Which
comes without mention or regard to any of the other
physiological modifications, or alleviation of pathophysio-
logical conditions, that arise throughout treatment that
has been noted in the continuum of fitness and fatness
factors impacting the overall health of the adult who is
overfat [17-21]. This single focus on body mass alteration
alone, leads to growing confusion within the general
population as it relates to which therapeutic intervention
may provide greatest benefit. Especially, given that there
are any number of anecdotal, and single study results, in-
dicating effectiveness of any of the various methods for
weight loss and health improvement for the adult who is
overfat. And more so are discussions of such reports
within the scientific community, and popular press, which
increase such confusion by indicating distinct advantages
(or disadvantages) that are in conflict with each other. Butalso indicate the aforementioned limited differences be-
tween methods of intervention for the adult who is
overfat.
Moreover, the differences between intervention methods
used within single studies and the methods of comparison
within previous reviews, lead to inherent issues of com-
parability of absolute changes between studies and the
conclusion stipulated thereby [22,23]. In particular, the
wide differences in the length of interventions and the vast
elaboration and complexity within the design of some in-
terventions utilized. Where most of the complexities that
appear in some programs are at a level of elaboration for
the sake of being elaborate, to function as a marketing
ideal, and not based on the elaboration necessitated by
principles of periodization and progressive training
[24,25]. Likewise, the length of intervention time between
comparisons varied greatly. Where, not surprisingly, the
longer the intervention the greater absolute change rela-
tive to a shorter duration intervention. And taken to-
gether, may be the underlying rationale for the perplexing
stats. Where even given an elevated current awareness of
health issues of overfatness, there are reports by the
Centers for Disease Control and Prevent (CDC) [1] identi-
fying that fewer than 21% of US adults meet the general
recommendation for exercise behaviors. And that only ap-
proximately 51% of US adults meet the recommendation
for aerobic (endurance) training while only 29% meet the
recommendation for strength (resistance) training each
week [1,3].
Even if it is well understood that altering any health
behaviors leads to a reduction in the risk factors for pre-
ventable non-communicable diseases [18,20,26-33]. And
can lead to greater use of other healthy behaviors leading
to greater overall levels of fitness [15,27]. Where these
improvements appear to stem from a number of endo-
crinological changes that occur with both expression of
overfatness and following exposure to exercise that ul-
timately alters the health status for the individual who is
overfat [18,19,26,28,30,32-34]. The greatest impact of
these changes appears to be related to alterations in sex
hormone (i.e. testosterone and androgens), growth hor-
mone, and a host of adipokines [29,34-46]. With low
utilization of healthy behaviors eliciting changes indi-
cated to increase the risk for the development of meta-
bolic issues, which may culminate in Type 2 Diabetes
Mellitus (T2DM), and are readily associated with re-
duced work capacity and anabolic hormone response for
the individual who is overfat [18,26,27]. And are re-
versed with exposure to physical activity (e.g., exercise)
with speculation that resistance exercise may provide
the greatest impact on reversing such issues [28,47-50]
and evidence for greater change in body composition
from utilization of resistance exercise, both with and
without conjunction with hypocaloric diet [51].
Clark Journal of Diabetes & Metabolic Disorders  (2015) 14:31 Page 3 of 28Given this level of understanding, it is perplexing that
there would be such low investment in beneficial health
behaviors that are highly associated with alleviating
many of the aforementioned health issues [19,26,28,31].
Which leads to the question, if it is generally understood
that physical activity is beneficial to not only in body
mass reduction, in particular fat mass (FM) but not fat-
free mass (FFM), along with improvements in many
health functions, then why are so few adults engaging
in such behaviors? As it has been reported that some
5-million U.S. deaths from non-communicable diseases
could be prevented, even with a possible stagnation in
the total proportion of the population classified as over-
weight or obese via current measures [1,2]. And may be
related to the way in which exercise (in particular RT) is
discussed in relation to the alteration of body mass,
resolving metabolic issues and improvements in the
overall health status for the adults who are overfat
[20,21,52-54]. Along with the means by which we dis-
cuss changes elicited along with the process of compari-
son and generalization of findings to the population
large. And a methodological bias in the employment of
exercise that leads to an over recommendation of a
single type of exercise based on personal preference
[27,55-57]. Which, is compounded by the trove of anec-
dotal reports for response, from a self-professed exercise
expert, that are easily accessible via any Internet search-
engine for topics related to issue of weight loss.
However, just because there are issues related to direct
comparison, due to methodological differences and tak-
ing into account the large inter-study discrepancies for
responses, one can still compare responses. Comparison
of responses must not come from the absolute value for
changes indicated by each study, but as performed here
through the aggregation of responses based on the
pooled effect for ES that over the sum of all studies.
Thus reflecting a more reliable overall effectiveness and
provide a greater insight into the treatment phenomenon
being offered [22,23]. Therein, the focus of this review
here will examine the various outcomes from treat-
ments utilized for improvements in the health status for
the individual who is overfat that can be incorporated
long-term behavioral modification. With analysis based
on the effectiveness of treatment (e.g., effect size, ES)
and not on the evaluation of absolute changes relative
to either the initial state, or in comparison to a control
group, within the included studies. Thus providing
support to the health-care practitioner, or fitness club
employee, to advice patients (or clients) as to which proto-
col schematics should provide the most effective means to
not only change body composition (thus providing the
reinforcement reward to elicit continual behavioral modi-
fication) but also improve the health status for the adult
who is overfat.Hence, the purpose of this systematic review is explore
the current understanding of changes elicited to body
composition in light of the understanding related to the
endocrinological and health improvements seen with the
various intervention programs based solely on population-
based studies. That is related to treatment utilization of
diet, diet and exercise or strictly exercise intervention for
means of body mass reduction (i.e. weight loss), change in
blood lipids and hormone levels. In an attempt to address
the question if there is a difference in response between
the various methods in (not absolute loss but effect size
for) loss of body mass, fat mass and fat-free mass along
with changes in blood lipid profiles and hormonal levels?
Upon which, analysis will examine four distinct hypoth-
eses. First, that exercise interventions will provide a
greater effectiveness means for FM reduction than any
diet intervention. Second, within exercise methods the use
of RT will provide a stimulus that induces a greater effect-
iveness for change in body mass change (reduction in FM
with retention of FFM) than ET, without regard to the
addition of diet to the intervention. Thirdly, exercise will
provide the stimulus that is more effective than any diet
intervention at reverse hormone and adipokine/cytokine
signals to normal “healthy” ranges. Lastly, that RT will be
able to produce an effectiveness of treatment that matches
the effectiveness of treatment from ET for both altering
hormone and adipokine/cytokine signals but also for
changing blood lipids.
Methods
As shown in the overview of the study in Figure 1, rele-
vant studies (e.g., studies only involving human volun-
teers that fit into category of population based evidence)
were retrieved from electronic database search engines
(PubMed, EBSCO Host (CINAHL, SPORTDiscus) and
Scopus) using the following key words in combination
with each other: obesity, exercise, resistance training, en-
durance training, strength training, aerobic training, diet,
adipokine (adiponectin, leptin), cytokine (CRP,IL-1, IL-6,
IL-10, TNF-α), anabolic hormone(testosterone, growth
hormone),thyroid hormone, insulin, inflammation, weight
loss, fat mass, and fat-free mass. From the journal arti-
cles returned by the search engine, articles were in-
cluded and excluded based on the following criteria.
Additional studies were determined to be included for
review based on citations within relevant articles.
Inclusion criteria:
 Published original research from January 1980-April
2013
 Published in English or translation of article
available
 Utilized only human participants with reported
average age for volunteers ranging from 18 and
Figure 1 Description summarizing the steps for inclusion/exclusion and method leading to classification and analysis of studies involved within
the meta-analysis.
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 Study population was either identified as either
“overweight” or “obese” by authors or was indicated
within the study as meeting at least 1 of the
classification metrics for being overweight or obese
(i.e. BMI > 25 kg/m3 or WHO levels of %BF for
classification based on age and gender)
 Studies compared at least two conditions (either
within subject cross-over design or comparison to a
control or basal/baseline) and involved random
assignment to training group(s) or control and to
the order or method of training
 Study designs examined chronic adaptations (i.e.
multiple training sessions, or interventions lasting at
least 4 weeks in duration)
 Main purpose was to examine hormonal or cellular
responses to exercise or diet
 Main purpose was to examine changes in body mass
in response to exercise or diet
 Main purpose was to examine chronic responses to
either exercise modes (e.g., resistance exercise orendurance exercise), hypocaloric diet, or
combination of one of the exercise modes with
hypocaloric diet, or combination of both exercise
modes with hypocaloric diet.
Exclusion criteria:
 Publication was a review article
 Not published in English or no translation available
 Study design utilized an animal model for the
problem
 Population age could be classified as adolescent, or
juvenile, (average age < 18 years of age) and/or
elderly (average age > 65 years of age)
 Study population either failed to meet metrics for
classification as “obese” or “overweight”, or was
indicated to have secondary disease (e.g., cancer,
osteoporosis, cardiovascular disease) or had
populations indicated to have history of metabolic
variables and concurrent treatments (e.g., smoking,
pharmacologically controlled type-2 diabetes
mellitus (T2DM), cardiovascular diseases) that
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treatment
 Study design did not randomly assign subjects to a
training group or control, or order of intervention
 Study design examined strictly acute responses (i.e.,
single exercise bout, or intervention lastly fewer
than 4 weeks in duration)
 Main purpose did not involve measure of hormonal
or cellular response to exercise or diet
 Results did not report absolute changes in hormones
or body mass following intervention
 Indication of use of dietary supplement, or
pharmacological dosing of anabolic or androgenic
hormones.
Following retrieval and evaluation for inclusion, study
data (reported means and standard deviation/error for
measures of interest, number of subjects in each study
groups, duration of study) were entered into database
for subsequent analysis, see Figure 1. From the initial ab-
stracts screened, a total of 66 studies were included in
the meta-analysis, from which 162 study groups were in-
cluded for comparison of responses within the review.
Each included study was then classified by parameter of
measurement and method, along with categorization of
the method, of therapeutic intervention, see Table 1, for
pooling and tabulating data for analysis based not only
on the outcome of measure but for demographic infor-
mation. From this pooled data for treatment responses
averages, standard deviations were calculated across the
studies classified by therapeutic intervention and meas-
ure of interest regardless of duration of intervention or
any additional unique characteristics of the individual
studies. Following which, pooled ES and confidence in-
tervals (CI.95) of ES for each measure of interest was de-
termined to examine the overall effect relative to a case
of no change (i.e. CI.95 crossing zero within the 95% of
all expected scores) based on each of the following com-
parisons, 1) relative to diet-only interventions; 2) relative
to combination of diet and ET interventions; 3) relative
to the combination of diet and RT interventions; and 4)
relative to the combination of diet with ET and RT
interventions.
In order to complete comparisons between dissimilar
experimental designs, all studies were evaluated for a stan-
dardized effect size (ES). Based on the premise for com-
paring ES previously utilized [58-60], for each of the
measures of interest based on the therapeutic intervention
(Figure 1). This standardized ES across all studies was
undertaken in an effort to control for difference in
methods of measurement and distinct (unique) qualified
differences in the therapeutic interventions (see Table 1).
And thus allow for comparison between and within the
various parameters measured based on the therapeuticintervention in a pooled fashion of ES for response. Each
of measure of interest and within all groups (interventions
as well as indicated control) the treatment ES were cal-
culated via (μpost− treatment − μpre − treatment)/(σpooled within).
After which, each measure of interest had a pooled ES
determined between the various treatment protocol group-
ings and the control grouping to elicit the pooled thera-
peutic effect, via equation (μchange treatment − μchange control)/
(σpooled with control). Additional comparison of the pooled ES
for changes were made on between the responses noted in
the various measures of interest across, and relative to the
pooled response for the control groups, indicated in the
studies included in the analysis, based on the equation,
(μchange across− treatment # 1 − μchange across − treatment # 2)/
(σpooled between treatment). Following which, a standardized
confidence interval (CI) for ES was calculated within
each treatment intervention for use in the comparison
of responses between interventions for each measure
of interest based on the pooling of studies for
comparison.
In an effort to establish a secondary directionality for
difference between treatments, the within study treatment
ES were then clustered for 2x2 χ2 analysis to determine if
any difference in the level of response, standardized ES, by
outcome based on the measure of interest for comparison
between responses based on relationship (i.e. above or
below) to the pooled ES for that given treatment, and
compared between the type of treatment and then based
on sub-classification of physical activity within the treat-
ment (e.g., resistance exercise, RT, endurance exercise,
ET, organized exercise program, or general physical ac-
tivity program), type of diet (e.g., general hypocaloric,
low-fat, or low-carbohydrate diet), the combination of
the diet with exercise programs, and based on the length
of intervention within the grouping of treatment.
Results
Pooled effects
As seen in Table 2, there are a wide variety of results
that were obtained from each of the therapeutic inter-
ventions utilized. Not only for the reduction of body
mass (including FM and FFM) but also for changes in
adipokines, hormones, and blood lipid profiles. Such
findings indicate that all treatments provide an effective
means to elicit change relative to status at start of treat-
ment or to the control treatment. Interestingly, there
were differences noted between effects favoring the
combination of diet with ET versus diet alone for
alterations in body mass (χ2 = 3.09, p = 0.055). And dif-
ferences indicate an effectiveness favoring for the com-
bination of diet with RT versus diet along for reduction
in FM (χ2 = 3.8, p < 0.05) and retention of FFM (χ2 = 6.7,
p < 0.0001). With no significant difference noted be-
tween the effectiveness for diet with ET or diet with
Table 1 Summary of studies include in meta-analysis indicating the therapeutic intervention used, and the principle measure of interest reported used for
comparison within analysis
Study Therapeutic intervention
(Group (N) size & gender
of treatment group)
Duration Summary description of therapeutic intervention Measures of Interest
reported for comparison
Ahmadizad [83]$ ET (8-M) 3x’s/wk for 12-wk ET: 75–85% of MHR for 20-30-min (progressive), BM, I, Adip
RT (8-M) RT: 4x12 CRT of 11 exercises @ 50–60% 1RM
Anderssen [84] D (34-M) ET: 3x’s/wk for 52-wks D: Low Fat BM, FM, FFM, Cal
ET (34-M) ET: 60–80% of PHR for 60-min
D(E) (43-M)
Ara [85] RT (12-M) RT: 3x’s/wk for 6-wks RT: 1–3 x 3–12 @ Progressive 1RM (range 50-90%) for Squats, Leg Press, Leg
Curl/Ext, Hip Flexion w/ 90 s rest @ total expenditure of 220–300 kcal/session
BM, FM, FFM, T, OB
Ballor [86] ET (9-M) 3 x’s/wk for 12-wk ET: 50% VO2max x 20–60 min (progressive) BM, FM, FFM
RT: 3x8 @ 50-80% 1RM (progressive) Squat, Bench, Leg Ext/Curl, Arm Ext/Curl,
Lateral Pulldown
RT (9-M)
Ballor [87] D (10-W) RT: 3x’s/wk for 8-wks D: hypocaloric @ -1000 kcal/day w/ Protein >1.0 g/kg BM, FM, FFM, Cal
RT (10-W)
D(R) (10-W) RT: 3x10-12 @ 10RM for: Chest Press, Leg Press, Lateral Pull-down, Arm Curl/Ext,
Leg Curl/Ext, Calf Raise
Borg [88] D (90-M) D: 2-month ET&RT:
3x’s-wk for 24-wk
D: Hypocaloric @ =1200 kcal/d for first and last wk and −500 kcal/d between BM, FM, FFM, Cal
ET (25-M)
RT (28-M) ET: 45 min @ 60-70% VO2max
RT: 3x8 @ 60-80% 1RM CRT
Bouchard [51] D (11-W) RT: 3x’s/wk for 12-wk D: Hypocaloric @ BM, FM, FFM
RT (11-W) −500 kcal/d
D(R) (12-W) RT: 3x8 @ 80% 1RM for (leg press, chest press, leg extension, shoulder press, sit-up,
seated row, triceps extension, arm curl, and calf extension) w/ 60–90 s rest
Brehm [89] D, LF (20-W) 24-wks D,LF: Hypocaloric @ ≈ 1250 kcal/d with ~54% CHO, ~18% protein, ~28% fat of kcal/d BM, FM, FFM, TC, TG,
LDL, HDL
D, LC: Hypocaloric @ ≈ 1160–1300 kcal/d with ~15-30% CHO, ~25% protein, ~46-57%
fat of kcal/d
D, LC (22-W)
Brochu [90] D (71-W) RT: 3x’s/wk for 24-wk D: Hypocaloric @ -500 kcal/d BM, FM, FFM, TC, HDL,
LDL, TG, CRP, I, Cal
RT: 3–4 x 8–12 @ 65-80% 1RM (progressive) for (Leg Press, Chest Press, Lateral
Pulldown, Shoulder Press, Arm Curl/Ext) w/ 60–90 s rest
D(R) (36-W)
Bryner [91] D(E) (2-M/8-W) ET: 4x’s/wk RT: 3x’s/wk
for 12-wk
D: Hypocaloric @ ≈ 800 kcal/d BM, FM, FFM, Cal
ET: 20–60 min (progressive) @ self-paced
D(R) (1-M/9-W) RT: 2-4x15-12 @ 15RM-to-8-RM (progressive) for 10-exercise CRT w/ 60-s rest
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RT: 3x8-12 @ 80% 1RM (for Leg Ext/Curl, Leg Press, Chest Press, Arm Pull) w/
60–120 s rest
Christiansen [93] D (29-M/W) ET: 3x’s/wk for 12-wk D: Hypocaloric @ ≈ 600 kcal/d BM, I, OB, TC, HDL, Cal
D(E) (25-M/W) ET: 60–75 min @ unknown intensity to equate to 500–600 kcal/session
ET (25-M/W)
Cuff [94] D(E) (10-W) 3x’s/wk for 16-wk E + R: 75-min @ 60-75% HRR w/ RT@ 2x12 for Leg Press, Leg Curl, Hip Ext, Chest
Press, Latissimus Pulldown @ unknown intensity or rest E: 75 min @ 60-75% HRR
BM
D(E + R) (9-W)
Donnelly [95]* D (26-W) ET & RT: 4x’s/wk for
12-weeks
D ET: 20–60 min (progressive) @ 70% HRR RT: 2–3 x 6–8 @ 70-80% 1RM (progressive)
on CRT exercises unknown, rest unknown
BM, FM, FFM, Cal
D(E) (16-W)
D(R) (18-W)
D(E + R) (9-W)
Donnelly [96]* D (7-W) RT: 3x’s/wk for 12-wks D: Hypocaloric @ =700 kcal/d BM, FM, FFM, Cal
RT: 3 sets 8,6,6 @ 70% 1RM, progress to 4 sets 8.6.6.4 @ 80% 1RM for Bench Press,
Latissimus Pull-down, Leg Ext/Curl, Shoulder Press, Arm Pullover, Arm Curl/Ext
D(R) (7-W)
Donnelly [97]$ ET (16-M/25-W) 5x’s/wk for 68-wks ET: 20–45 min @ 60%-75% HRR for 1st 24-wks then 55%-70% of HRM (progressive)
for ≈ 2000 kcal/wk (400 kcal/session)
Dunstan [98]*$ D (17-M/W) RT: 3x’s/wk for 24-wks D: Hypocaloric BM, FM, FFM, I, TC, HDL,
LDL, TG, Cal
RT: 3x8-10 @ 50-85% 1RM (progressive) for Bench Press, Leg Ext/Curl, Upright Row,
Lateral Pull-down, Shoulder Press, Arm Curl/Ext, Abdominal exercises
D(R) (19-M/W)
Fisher [99]*$ D (29-W) ET & RT: 3x’s/wk for 8-wks D: Hypocaloric @ ≈ 800 kcal/d BM, FM, FFM, CRP, IL-6,
TNF-α, Cal
ET: 20–40 min @ 65-80% MHR (progressive)D(E) (43-W)
RT: 1-2x10 @ 60-80% 1RM (progressive) for Leg Press, Squats, Leg Ext/Curl, Arm
Curl, Lateral Pull-down, Bench Press, Military Press, Trunk Exercises
D(R) (54-W)
Foster [100]* D, HP (12-M/21-W) 52-wks D, HP: Hypocaloric following Dr. Atkins New Diet Revolution BM, FM, FFM, Cal
D (8-M/22-W) D: Hypocaloric @ M ≈ 1500–1800 kcal/d; W ≈ 1200–1500 kcal/d for 60%CHO, 15%
protein, 25% fat
Geliebter [101] D (8-M/14-W) ET & RT: 3x’s/wk for 8-wks D: Hypocaloric @ <70% RMR BM, FM, FFM, Cal
D(E) (9-M/14-W) ET: 8-min bicycle erg, 8-min arm erg, 8-min cycle erg @ 55-70% VO2peak (progressive)
D(R) (8-M/14-W) RT: 2x6, 1xfatigue for Leg Ext/Curl, Chest Press, Arm Pull-over, Arm Curl/Ext, Leg Press
w/30 s rest
Goddpaster [102] D (63-M/W) ET: 5 d/wk for 24-wks D: Hypocaloric @ ≈ 1200–2100 kcal/d with 50-55% CHO, 20-25% protein, 20-30% fat BM, FM, FFM, Cal
D(E) (67-M/W) ET: total 60-min/d unknown intensity
Hallsworth [103] RT (11-M/W) 3x’s/wk for 8-wks RT: 2–3 sets x unknown rep @ 50-70% 1RM (progressive) for: Arm Curl/Ext, Chest Press,
Leg Curl/Ext, Lateral Pulldown, Shoulder Press
BM, I, TC, TG
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D, VL (12-W)
ET (12-W) ET: distance of 1.6-4.8 km/session (progressive) @ 60-85% HRM (progressive)
D(E), LF (8-W)
D(E), VL (6-W)
Hill [105] D (3-W) ET: daily for 5-wks D: hypocaloric @ 800 kcal/d BM, FM, FFM
D(E): distance of 1.6-5.6 km/session (progressive) @ unknown intensityD(E) (5-W)
Hill [106] D (6-W) ET: 5x’s/wk for 12-wks D: hypocaloric vary from 600–1500 kcal/d, LF @ 1200 kcal/d BM, FM, FFM
D, LF (8-W)
D(E) (10-W)
D(E), LF (8-W) ET: 20–50 min (progressive) @ 60-70% HRM
Ho [107] D(E) (15-M/W) ET & RT: 5x’s/wk for
12-wks
D: hypocaloric BM, FM, FFM, I, OB, TC,
HDL, LDL, TG, Cal
ET: 30-min @ 60% HRR
D(R) (16-M/W) RT: 4x12 @ 10RM for Leg Press, Leg Curl/Ext, Bench Press, Seated Row w/ 60 s rest
D(E + R) (15-M/W) E + R: ET for 15-min @ 60% HRR & RT for 2x12 @75%1RM
Ibanez [108] D (12-W) RT: 2-3x’s/wk for 16-wk D: Hypocaloric @ -500 kcal/d BM, FM, FFM, I, Adip, OB,
TC, HDL, LDL, TG, Cal
RT: 3-4x10-15 @ 50-80%
D(R) (13-W) 1RM (progressive) CRT for 8-wks & 3-5x10-12@60-80% or 3-5x 4-6@80-90% alternate
for 8-wks
Irving [109]$ E(Low-Intense) (3-M/10-W) 3-5 x’s/wk for 16-wks Low-Intensity: unknown time @ RPE of 10–12 equate to 300–400 kcal/session BM, FM, FFM, GH, IGF,
HDL, TG, Cal
E(High-Intense) (3-M/8-W) High Intensity: unknown time @ RPE of 15–17 to equate to 300–400 kcal/session
Josse [110]$ D(E + R), HP (30-W) ET: 7x’s/wk RT: 2x’s/wk
for 16-wks
ET: 7x’s/wk @ total expenditure of 250 kcal unknown duration or intensity BM, FM, FFM, Cal, IL-6
D(E + R), LP (30-W)
D(E + R), MP (30-W) RT: 3x10 unknown intensity & rest interval
Kempen [111] D (10-W) ET: 3x’s/wk for 8-wks D: Hypocaloric @ =500-750 kcal/d BM, FM, FFM, Cal
D(E) (10-W) ET: 90-min group exercise sessions @ 50-60% VO2max
Kerksick [112]$ E + R (17-W) ET&RT: 3x’s/wk for 14-wks E + R: @ HR of 60-80% MHR using CRT of 14 exercises either paired: BM, FM, FFM, Cal
D(E + R), HC + P
(11-W)
D(E + R),VL/HP Arm Ext/Curl, Leg Ext/Curl, Shoulder Press/Lateral Pulldown, Hip Abd/Add, Chest
Press/Seated Row, Abdominal Crunch/Back Extension, Shoulder Shrug/Dip; or
unpaired: Leg Press, Squat, Pec-Deck, Oblique, Hip Ext, side bends, stepping) x
30 s @ unknown %1RM w/ callisthenic 30 s between sets/paired exercise
(48-W) D(E + R),LC (37-W)
D(E + R),HC (41-W)
Klimcakova [113]$ D(R) (12-M) RT: 3x’s/wk for 12-wks D: Hypocaloric BM, FM, FFM, I, Adip, OB,
TNF-α, TC, HDL, TG
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Kraemer [114] D (8-M) RT & ET: 3x’s/wk for
12-wks
D: Hypocaloric BM, FM, FFM, Cal
ET: 30–50 min (progressive) @ 70-80% PHR
ET&RT: ET then, 1-3x5-10 @5-7RM or 8-10RM (alternate) for Squat, Military Press,
Bench Press, Lateral Pull-down, Seated Row, Trunk exercises, Leg Press, Leg Curls,
Calf Raises, Arm Curls with 60–180 sec rest (load dependent)
D(E) (11-M)
D(E + R) (10-M)
Larsen [115]* D, HGI/HP Hypocaloric for 26-wks All diets w/ < 25-30% total kcal from fat BM, FM, FFM, Cal
(97-M/W)
D, LGI/HP LP: PRO:CHO ratio of 1:5 (10–15% total kcal protein and 57–62% total kcal CHO)
(124-M/W)
D, HGI/LP HP: PRO:CHO ratio: of 1:2 (23–28% total kcal protein and 45–50% total kcal CHO)
(106-M/W)
D, LGI/HP HGI: no change in GI diets w/ ~ 12% total kcal from protein
(124-M/W) LGI: reduction of 15 GI points compared with the high-GI diets w/ ~ 12% total
kcal from protein
Layman [116]* D, HP (12-W) 10-wks D, HP: ≈1700 kcal/d @1.6 g/kg protein in ratio of CHO:protein ~1.4 and <30% fat
of kcal/d
BM, FM, FFM, I, TH, TC,
HDL, DLD, TG
D, HC (12-W) D, HC: ≈1700 kcal/d @0.8 g/kg protein and ratio of CHO:protein >3.5 and <30% fat
of kcal/d
Layman [117]$* D, HP (12-W) ET: 5x’s/wk RT: 2x’s/wk
for 16-wks
D, HP: ≈1700 kcal @ 1.6 g/kg for protein with CHO:protein ratio <1.5 and fat <30%
of kcal/d
BM, FM, FFM, Adip, OB,
Ghrelin, I, TC, HDL, LDL,
TG, Cal
D(E + R), HP (12-W) D, HC: ≈1700 kcal/d @ 0.8 g/kg for protein with CHO:protein ratio >3.5 and fat <30%
of kcal/d
D, HC (12-W)
D(E + R), HC (12-W) ET: 30-min @ unknown intensity
RT: 1x12 @ unknown resistance intensity for 7 exercise in CRT
Maiorana [118]$ E + R (14-M/2-W) 3x’s/wk for 8-wks E + R: CRT for RT @ 45 s of RT @ 55–65% MVC (progressive) w/ 15 s rest between
RT followed by 5-min ET @ 70–85% PHR (progressive) intermittent to RT-exercises
BM, HDL, LDL, TC, TG
Marks [119] D (10-W) ET & RT: 3x’s/wk for
20-wks
D: Hypocaloric general low fat @ -628 kcal/d BM, FM, FFM, Cal
ET: 12–36 min (progressive) @ 70-85% HRMD(E) (8-W)
D(R) (11-W) RT: 2x8-12 @ 70-90% 1RM for: Leg Ext/Curl, Seated Row, Chest Press, Arm Ext/Curl,
and abdominal curls, with unknown rest
D(E + R) (9-W)
ET&RT: 12–24 min of ET and 1 set of RT
Moreira [120]$ E(S) (8-M/W) 3x’s/wk for 12-wks E(S):20–60 min (progressive) @ 10% of Anaerobic Threshold BM, FM, FFM, TC, TG
E(I): 20–60 min (progressive) total time @ 2:1 ratio of 120% Anaerobic Threshold to
Rest time
E(I) (8-M/W)
Nicklas [121] D (53-M/W) ET & RT: 3x’s/wk for
72-wks
D: Hypocaloric @ -500 kcal/d BM, CRP, IL-6, TNF-α, Cal
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E + R: 15-min ET @ 50-75% HRR, followed by 15-min RT @ 2x12 CRT, followed by
15-min ET @ 50-75% HRR
D(E + R) (53-M/W)
Oberbach [122]$ ET (40-M/W) 4x’s/wk for 4-wks ET: 3-days: 60-min unknown intensity (20-min calisthenics/20-min steady
state/20-min “power-training” & 1-day: 60-min swimming
BM, FM, FFM, Adip, OB,
IL-6, IL-10, CRP, TC, HDL,
LDL, TG
Olson [123] RT (16-W) 2x’s/wk for 52-wk RT: 3x8–10 @ 8-10RM (Progressive) for unknown exercises indicated as isotonic
variable resistance machines and free weights targeting the following major
muscle groups: quadriceps, hamstrings, gluteals, pectorals, latissimus dorsi,
rhomboids, deltoids, biceps and triceps
BM, FM, FFM, I, Adip, Il-6,
CRP, TC, HDL, LDL, TG
Pavlou [124]*$ D (41-M) ET: 3x’s/wk for 8-wks D: Hypocaloric @ = 800 kcal/d BM, FM, FFM
D(E) (31-M) ET: 70-85% MHR for 20–45 min (progressive)
Phinney [125] D, HP (6-W) ET: 6-hrs/wk for 4-wks D: hypocaloric @ =720 kcal/d BM, FM, FFM, Cal
D(E) (6-W) ET: 6-hrs/wk total time @ 50% VO2max
Polak [126] ET (25-W) 5x’s/wk for 12-wks ET: 45-min @ 50-65% VO2max (progressive) for 2x’s/wk group exercise class,
3x’s/wk cycle ergometer
BM, FM, FFM I, Adip, OB,
IL-6, TC, HDL, TG
Pritchard [127] D, LF: (18-M) ET: 5x’s/wk for 52-wks D: hypocaloric @ -500 kcal/d & 20-25% fat of kcal/d BM, FM, FFM, Cal
ET (21-M) ET: 30–45 min @ 65-75% HRM
Racette [128] D (17-W) ET: 3x’s/wk for 12-wks D: hypocaloric @ =75% BMR BM, FM, FFM, Cal
D(E) (13-W) D(E): 35-min @ 65% VO2max
Rice [129] D (9-M/W) ET: 5x’s/wk RT: 3x’s/wk
for 16-wks
D: Hypocaloric @ -1000 kcal/d BM, FM, FFM
ET: 20–60 min @ 50-85% MHR (progressive)D(E) (10-M/W)
RT: 1x8-12 @ 8-12RM (progressive) for Leg Ext/Curl, Latissimus pull-over, Bench
Press, Should Press, Arm Ext/Curl
D(R) (10-M/W)
Rolland [130]* D, HP (1-M/16-W) 36-wks D,HP: hypocaloric @ 800–1500 kcal/d, @ 20%CHO,40% protein, 40% fat of kcal/d BM, FM, FFM, I, Adip, OB,
HDL, TC
D, LF (5-M/9-W) D, LF: hypocaloric @ -500 kcal/d @ 35%, CHO, 36% protein, 28% fat of kcal/d
Ross [131] D (15-W) ET: daily x 14-wks D: Hypocaloric @ -500 kcal/d BM, FM, FFM, I, Cal
ET: self-selected duration @ ~80% MHR (equate to 500 kcal/session)D(E) (17-W)
ET (12-W)
Ryan [132]*$ D (23-W) ET & RT: 3x’s/wk for
24-wks
D: Hypocaloric @ -250-350 kcal/d BM, FM, FFM
ET: 45-min @ 50-75% HRR (progressive)D(E) (24-W)
D(R) (16-W) RT: variable resistance for 15-rep (3RM to 15 RM) 2–3 sets for Leg Press, Chest
Press, Chest Flies, Latissimus Pull-down, Leg Curl/Ext, Arm Curl/Ext w/ 30 s rest
Schjerve [133]$ E(S) (13-M/W) 3x’s/wk for 12-wks IT: 10-min @ 50-60% MHR followed by 4 cycles of 4-min:3-min ratio of 85-95%
MHR then 50-60% MHR followed by 5-min @ 50-60% MHR
BM, FM, FFM, TC, HDL, TG
E(I) (14-M/W)
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RT: 4x5 @ 90% 1RM (progressive) for Leg Press or Squats, trunk exercises @ 3x30
w/ 30 s rest
Shue [134] D (21-W) 12-wks D: Hypocaloric @ -500-1000 kcal/d I, Adip, OB, IL-6, IL-10,
TNF-α, TC, HDL, LDL, TG
Sigal [135] D(E) (60-M/W) ET & RT: 3x’s/wk for
24-wks
ET: 15–45 min @ 60-75% MHR (progressive) BM, FM, FFM, HDL, LDL,
TG
D(R) (64-M/W) RT:2-3x7-9 @ unknown intensity in CRT w/ unknown exercises
D(E + R) (64-M/W) E + R: combined both
Slentz [136] ET (22-M/26-W) 3x’s/wk for 32-wks ET: equivalent to 12 mi/wk @ 75% VO2peak BM, FM (as indicated by
abdominal)
RT (22-M/30-W) RT:3x8-12 @ unknown RM in CRT fashion
E + R (19-M/25-W) E + R: full sessions of both ET & RT
Strasser [7]*$ D (10-W) ET: 3 x’s/wk for 8-wks D: Hypocaloric @ -500 kcal/d BM, FM, FFM, TC, HDL,
LDL, TG, Cal
D(E) (10-W) ET: 60-min @ 60% VO2max
Tjønna [137] E(I) (4-M/7-W) 3x’s/wk for 16-wks IT: 10-min @ 70% MHR followed by 4-cyles of 4-min:3-min @ 90% MHR and 70%
MHR, then 5-min @ 50-60% MHR
BM, FM, FFM, I, Adip,
HDL, TG
E(S) (4-M/4-W)
ET:47-min @ 70% MHR
Tokmakidis [138]$ D(E + R) (9-W) 4x’s/wk (2x’s ET, 2 x’s RT)
for 16-wks
ET: 2x’s/wk: 45-min @60-80% MHR (progressive) BM, FM, FFM,I
RT: 2x’s/wk: 3x12 @ 60% 1RM (progressive) for Bench Press, Row, Leg Ext/Curl,
Latissimus, Pec Deck w/ 45–60 s rest Pull-down,
Trapp [139] E(I) (15-W) 3x’s/wk for 15-wks IT: cycle ergometer @ 8-sec sprint:12-sec recover intervals progress from 5-min to
20-min total time
BM, FM, FFM,I, Adip, OB
E(S) (15-W)
ET: 10–40 min @60% VO2peak (progressive)
Volpe [140]*$ D (13-M/15-W) ET: 3–5 x’s/wk for 36-wks D: hypocaloric @ ≈ −500 kcal/d BM, FM, FFM, OB, TC,
HDL, LDL, TG, Cal
ET (17-M/17-W)
D(E) (14-M/14-W) ET: 15–30 min for 3–5 x’s/wk (progressive) @ unknown intensity via ski-ergometer
Wang [141]* D, HGI/HP(24-W) 8-wks hypocaloric and
24-wks 1 of 4 maintaining
diets
D: 8-wks of low fat/ Hypocaloric @ =800 kcal/d & 24-wks of: BM, I, TC, HDL, LDL, TG,
Cal
LF: < 25-30% total kcal from fat with compensatory increase in protein and CHOD, LGI/HP (24-W)
D, HGI/LP (24-W) LP: PRO:CHO ratio of 1:5 (10–15% total kcal protein and 57–62% total kcal CHO)
HP: PRO:CHO ratio: of 1:2 (23–28% total kcal protein and 45–50% total kcal CHO)D, LGI/HP (24-W)
HGI: no change in GI diets w/ ~ 12% total kcal from protein
LGI: reduction of 15 GI points compared with the high-GI diets w/ ~ 12% total
kcal from protein
Watkins [142] ET (14-M/W) ET: 3–4 x’s/wk for 26-wks D: hypocaloric @ ≈ 1200–1500 kcal/d w/ fat @ 15-20% total kcal/d BM, FM, FFM, I, TC, HDL,
LDL, TG, Cal
D(E) (14-M/W) ET: 30–35 min @ 70-80% HRR
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D(R) (17-M/W) D,HP: Hypocaloric @ ≈ 1200-
1250 kcal/day @1.2 g/kg protein
D(R), HP (14-M/W) RT: 2x8-12@70-85% 1RM for Leg Press, Leg Ext, Chest Press, Latissimus
Pull-down, Seated Row, Arm Ext w 60 s rest
Note *denotes only treatment ES determined for diet-only intervention, $denotes only treatment ES determined within exercise interventions. Legend: D = diet, RT = resistance training, ET = Endurance Training, E + R =
combination of exercise, HP = high protein diet/low carb, HC + P = high carbohydrate & protein, HC = high carbohydrate/low fat, GI = glycemic indexed diet, HGI = high glycemic diet, LGI = low glycemic diet, LC = low
carb/no protein change, LF = low fat (American Heart Assoc.), VL = very low caloric diet, LP = low protein, MP =moderate protein, D(R) = diet and resistance training, D(E) = diet and endurance training, D(E + R) = diet
and combination of exercise, E(S) = steady state endurance, E(I) = interval endurance training, MHR =maximal heart rate; PHR = peak heart rate, HRR = heart rate reserve, CRT = circuit resistance training, IT = interval
training, MVC =maximal volitional contraction, RPE = rating perceived exertion, TC = total cholesterol, HDL = high-density lipoproteins, LDL = low-density lipoproteins, TG = triglycerides, T = testosterone, GH = growth
















Table 2 Summary of response based on the pooled therapeutic effect size (ES), from the 32 studies that indicated
control group, ES (CI for ES), based on method of therapeutic intervention and measure of interest
Pooled ES (CI)
Body Masses: D D(E) ET D(R) RT D(E + R)
Body mass 1.24(0.25, 2.23) 1.19$(0.14, 2.25) 0.2¢(−0.38, 0.78) 1.06#(0.07, 3.12) 0.25(0.007, 0.42) 0.57(0.29, 0.84)
Fat mass 0.88(0.22, 1.53) 1.07$(0.41, 1.73) −0.16¢(−0.80, 0.49) 0.63#¢(0.13, 1.57) 0.36(−0.30, 0.59) 0.14(−0.86, 1.13)
Fat-free mass 0.48(0.001, 0.95) 0.02$(−1.05, 1.08) 0.80(0.61, 0.99) 1.08*#¢(0.61, 1.56) 2.23*(−1.5, 5.95) 0.20(−0.18, 0.57)
Hormones, Adipokines,
Cytokines:
Insulin 0.30(−0.03, 0.63) 0.55(−0.24, 1.34) 0.11(−0.49, 0.72) 0.47#(0.01, 0.95) 0.79(−0.81, 2.39) 0.30(−0.03, 0.63)
Adiponectin 0.13(−0.18. 0.43) −0.84$(−3.01, 1.33) 1.27(−0.02, 2.54) 1.35#(−0.66, 3.36) 1.05(−0.05, 2.14)
Leptin −0.38(−1.88, 1.11) 1.57(1.25, 1.90) 1.07#(0.46,1.67) −0.38(−1.88, 1.11)
Blood Lipids:
Total cholesterol 0.39(−0.13, 0.90) 0.16$(−0.35, 0.67) −0.16(−0.67. 0.34) 0.32(−1.13, 1.76) 0.001(−0.22, 0.22) 0.93
HDL 0.11(−0.14, 0.37) 0.38$(−0.13, 0.90) 0.96(0.31, 1.60) −0.31*#(−1.11, 0.48) −0.19*(−1.00, 0.62)
LDL −0.01(−0.20, 0.18) −0.09$(−0.69, 0.50) −0.30(−0.33, −0.28) 0.04#¢(−0.89, 0.96) −0.45(−1.46, 0.56)
Triglycerides −0.05(−0.20, 0.11) 0.14$(−0.07, 0.24) −0.28(−0.81, 0.24) 0.24(0.03, 0.45) −0.27(−0.48, −0.06) 0.61(0.08, 1.14)
Caloric difference 0.48(−0.15, 1.11) 0.49$(−0.15, 1.13) 1.16*$(0.15, 2.18) 0.19(−0.50, 0.79) 0.48(−0.15, 1.11)
Note that a negative ES favors the control intervention while a positive ES favors the therapeutic intervention and that for measures of changes to fat-free mass,
the indication for retention of mass is considered to be positive. Cells left empty did not have enough responses to indicate either a pooled therapeutic ES relative
to control or a CI for ES. Note that D indicates intervention of diet only, ET indicates endurance training, RT indicates resistance training, D(E) indicates intervention
of diet with ET, D(R) indicates intervention of diet with resistance training, D(E + R) indicates intervention of diet with combination of training methods.
*Indicates significantly greater response than diet-only intervention, $Indicates difference between modes of endurance exercise intervention, #indicates difference
between intensity used for resistance exercise intervention, ¢indicates difference in gender response (male > female), ¢*indicates difference in gender response
(female >male), for χ2-value > χ2CV, p < 0.05.
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ness that favors RT over ET for FFM retention (χ2 =
10.15, p < 0.01). When examining the effect of ET, when
separated from the aspect of additional diet interven-
tion, ET alone appears to less effective to allow for the
retention of FFM than dieting alone, or in a combin-
ation with use of diet (χ2 = 7.458, p < 0.01). While the
use of RT, both alone as well as in combination with diet
provides greater stimulus for retention of FFM (χ2 = 3.5,
p < 0.05). There were also distinct differences noted in
responses based on gender and the type of treatment
utilized. Where males tend to have a larger pooled ES
for responses to diet with RT retention of FFM and re-
duction in FM relative to female groups (χ2 = 3.94, and
3.64, p < 0.05, respectively). Along with males indicated
has having a greater level of effectiveness relative to
females for loss of FM and retention of FFM following an
intervention of diet with combination of both ET and RT
(χ2 = 3.64, p < 0.05). While females trended toward hav-
ing a larger pooled ES for responses to diet alone, χ2 =
2.09 (p = 0.11), and in combination to ET for reduction
in total body mass, χ2 = 1.94 (p = 0.12), and FM, χ2 = 3.1
(p = 0.09), but not FFM. Lastly, as related to changes in
caloric (energetic) balance there were no differences
noted between any of the pooled ES for the assumed
differences in energetic balance across the various treat-
ment interventions.In comparison of blood lipid profiles, e.g., total choles-
terol (TC), high-density lipoproteins (HDL), low-density
lipoproteins (LDL), and triglycerides (TG), all treatment
options once again provided an effective means for
change relative to either the pre-intervention status or
in comparison to the control conditon. The responses
invoked by RT, whether alone or in combination with
diet, showed a greater effectiveness for eliciting changes
in TC and LDL relative to the diet only options (χ2 =
7.18, 4.95, respectively) and trends toward significance
for HDL (χ2 = 3.38, p = 0.068). But showed no difference
to the responses invoked by ET, either with or without
the combination of diet. While the use of ET either
alone, or in combination with diet, show no difference
for effectiveness at eliciting changes blood lipids (TC,
LDL and TG) versus the changes elicited by a diet only
intervention. Yet trended toward favoring ET for effect-
iveness in changes seen in HDL (χ2 = 2.842, p = 0.089).
Additionally, there were no differences noted on the
pooled effect for treatment based on the gender of the
participant groups for any of the treatment intervention
options. However there was a trend for women utilizing
ET in combination with diet for having a great effect in
the changes in HDL levels versus those seen in men (χ2 =
2.0, p = 0.12).
Similar to the changes seen with blood lipids, effect-
iveness for eliciting positive changes to adipokines
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(CRP), TNF-α) of interest were noted occurring from all
treatment interventions. Furthermore, there were very few
differences in the pooled effect size versus the diet only
intervention, with difference in ES for changes of adipo-
nectin and leptin being elicited by the use of RT, either
with or without diet, trending toward significant dif-
ference, χ2 = 3.085 (p = 0.07) and χ2 = 3.45 (p = 0.06),
respectively. While there were no differences noted be-
tween the therapeutic effectiveness for treatment in the
responses to either CRP or TNF-α between any of the
combinations for interventions.
Comparison between treatment effects
In comparison of body compositional changes based on
the method of intervention, as would be expected, there
are effect size differences in treatment responses that
favor the combination of intervention methods. While a
diet alone treatment did induce a beneficial treatment
effect following intervention. It was not more effectiveFigure 2 Description of the pooled ES for treatment response and the ran
with combination of ET, or versus diet with combination of RT) methods fo
(FFM). Note that the comparisons are labeled as “treatment-to-comparison”, w
with RT, D(E + R) indicating diet with ET and RT, ET indicating ET-only, an
the comparisons.than other treatments at inducing changes in FM, see
Figure 2. While the combination of diet and ET was not
as effective as any of the other treatments with respect
to changing of body composition. ET appears to be ef-
fective at inducing a larger loss of FFM relative to diet
with combination of RT (χ2 = 6.531, p = 0.01). With re-
spect to the combination of diet and RT, this interven-
tion appears to be able to induce favorable adaptions in,
measurements of both FM and FFM (χ2 = 9.24 and χ2 =
8.02, p < 0.01, respectively). While producing equivalent
ES for body mass changes as either diet alone, or diet in
combination with ET, see Figure 2. Interestingly, there
were no differences noted showing a favor toward the
combination of diet with both ET and RT versus the
other intervention methods. In continuation with what
was noted in the pooled therapeutic effect size, a trend
toward gender difference for effectiveness of treatment
was noted in the change in FFM for the utilization of
diet with RT only in male groups versus female counter-
parts (χ2 = 3.3, p = 0.06).ge of CI for ES between intervention (versus diet alone or versus diet
r changes in either Body Mass (BM), Fat Mass (Fat), and Fat-Free Mass
ith D indicating diet-only, D(E) indicating diet with ET, D(R) indicating diet
d RT indicating RT-only for the various intervention methods within
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favors an intervention that is a combination of diet with
any type of exercise versus that of either diet, or exer-
cise, alone, Figure 3. Furthermore, the treatment ES for
energetic imbalance for the combination of diet and ET
were more favorable than any other treatment interven-
tion combinations. Interestingly, while the combination
of diet with ET and RT was more effective then either a
diet alone or exercise alone it was less effective then ei-
ther ET or RT in combination with diet at inducing an
energetic imbalance. Additionally, there were no differ-
ences between gender groups that would indicate a greater
effectiveness of a treatment methodology for a specific
gender grouping.
In regards to changes in the blood lipid profiles,
there were not only indications for difference between
treatments, there is also a very interesting finding that
therapeutic interventions may actually induce eleva-
tions in certain lipids. While the diet only intervention
did have a positive impact on TC and HDL levels, itFigure 3 Description of the pooled ES for treatment response and the ran
with combination of either ET, RT, or combination of ET and RT) methods f
intervention protocol. Note that the comparisons are labeled as “treatment
ET, D(R) indicating diet with RT, D(E + R) indicating diet with ET and RT, ET
intervention methods within the comparisons.has only minimal impact on either LDL or TG levels,
Figures 4, 5 and 6. Additionally, the treatment inter-
ventions that combined diet with ET induced a much
larger ES, Figure 4, for measures TC and LDL. And diet
in combination with RT induces a larger ES in TC,
HDL, LDL and TG changes relative to those changes
seen in diet only treatments, Figures 4, 5 and 6. More-
over, diet with combination of RT was able to produce
a much lager ES for these measures in comparison to
those induced by diet with combination of ET, for each
of these measures, see Figures 4, 5 and 6. As far as
changes in TG, diet with combination of RT appears be
the least effective for inducing changes relative to ei-
ther the diet only or the diet with combination of ET,
Figures 4, 5 and 6. Additionally, there appears to be a
pattern where the induction for changes in lipid pro-
files cannot be established through the use of ET only
for all measures. While RT is the only intervention that
appears to be slightly more effective than diet alone or
diet in combination of ET for changes in HDL and TG,ge of CI for ES between intervention (versus diet alone or versus diet
or changes in energetic imbalance as assumed established within the
-to-comparison”, with D indicating diet-only, D(E) indicating diet with
indicating ET-only, and RT indicating RT-only for the various
Figure 4 Description of the pooled ES for treatment response and the range of CI for ES between intervention (versus diet alone) methods for
response related to changes in blood lipid profiles TC, HDL, LDL, and TG. Note that labeled groups go as follows: D indicating diet-only, D(E)
indicating diet with ET, D(R) indicating diet with RT, and D(E + R) indicating diet with ET and RT for the various intervention methods within
the comparisons.
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for effectiveness of treatment for HDL and TG but not
for LDL or TC, both of which indicate a larger effective-
ness for treatment in female grouping versus male
counterparts.
The most prominently reported hormones and cyto-
kine signal throughout the studies was insulin, followed
by adiponectin, leptin, IL-6, CRP, and TNF-α. And as
such are the hormone and cytokines reported on here as
they provide a large enough N-size to allow for compari-
son of a pooled ES and CI for ES based on treatment
intervention. In which ES for eliciting changes in insulin,
Figure 7, indicates that ET in combination with diet (or
as a stand-alone intervention) induces a lower effect
than diet alone. While the use of RT either alone, or in
combination with diet, was more effective than diet
alone it was less effective than ET or the combination of
diet with ET and RT, see Figure 7. There was a gender
difference to response and effectiveness indicated within
the analysis for insulin changes, with treatments appear-
ing to be more effective in male groupings than in female
groups.
There were highly variable responses for effective-
ness for each treatment method to induce changes tocirculating levels of adiponectin, leptin, TNF-α, or CRP
(Figures 8, 9 and 10). In which, diet alone and in com-
bination with ET, were more effective than what was
seen with changes induced by the incorporation of RT
for changes to adiponectin and leptin, Figures 8, 9 and
10. While the changes induced in CRP and TNF-α,
Figures 8, 9 and 10, were nearly identical, i.e. ES that
crosses 0, for differences in effectiveness for changes
between diet alone, or diet in combination with exer-
cise (either ET, RT or combination of ET and RT). And
all were more effective than the exercise alone treat-
ments. Further there were no indication for a more ef-
fective means to change cytokine or adipokine levels
with the utilization of diet in combination with both
ET and RT. Interestingly, there were no gender differences
indicated throughout the analysis of ES for any of the
changes to the level of cytokines or adipokines following
treatments, regardless of the methodology employed.Comparison within treatment methods
Not only were there differences indicated between the
treatment options, but also within the various treatment
methods. First is the differences based on diet method.
Figure 5 Description of the pooled ES for treatment response and the range of CI for ES between intervention (versus diet with combination ET)
methods for response related to changes in blood lipid profiles TC, HDL, LDL, and TG. Note that labeled groups go as follows: D indicating diet-
only, D(E) indicating diet with ET, D(R) indicating diet with RT, and D(E + R) indicating diet with ET and RT for the various intervention methods
within the comparisons.
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diet with >1.5 g protein*kg−1body mass (>25% of total
kcal/d), in a hypocaloric model inducing a larger effect
for body compositional changes relative to any of the
other diet methods, ES of 0.60, 0.54, 0.38 for loss of
body mass, FM and retention of FFM respectively. Fur-
ther, lower fat diet was less effective when compared to
either a glycemically controlled diet, or the high protein/
low carbohydrate diet for the change of any body com-
positional measures, ES of −0.64. Especially in relation
to the high protein/low carbohydrate diet, ES of −1.04.
Similarly, the lower carbohydrate and higher protein
model lead to a greater effect in changes to blood lipids
and cytokines (adiponectin and leptin) with an ES of
0.60, 2.14, 0.59, and 0.77, for TC, HDL, adiponectin and
leptin respectively.
Also exercise of high intensity (indicted as with RT
training intensities ≥75% of 1RM at a training volume of
2–4 sets of 6–10 reps and when free-weight resistance is
utilized or ET utilizing interval intensities or a steady-state
with intensities ≥70% VO2max or HRmax) elicited greater
effectiveness at inducing changes to body composition, in-
sulin levels, blood lipids, and cytokines (adiponectin, CRP,IL-6), with an ES of 0.49, 0.66, 0.37, 0.50, 0.75, 0.78, 0.75,
0.66, 1.15, and 0.92 for BM, FM, FFM, Insulin, TC, LDL,
TG, adiponectin, CRP, and IL-6 respectively. As should be
of no surprise, the combination of a high level of training
intensity (regardless of method of exercise, ET or RT or
ET and RT, or in combination with diet or not) induced a
greater effect on the level of energetic imbalance than a
lower level of training intensity. When comparisons based
on training intensity indicate a clear preference towards
use of higher levels of training intensity. Where higher in-
tensity training once again elicited a greater effect in the
responses than lower intensities (ES of 0.66, 0.3, 0.42,
1.15, 0.92 for adiponectin, leptin, TNF-α, CRP and IL-6
respectively). And is better than the diet only option for
treatment (ES of 0.26, 0.59, 0.29, 0.86, 0.33 for adiponec-
tin, leptin, TNF-α, CRP and IL-6 respectively). Compari-
son between exercise modalities indicates RT protocols
produced a greater ES for changes in adiponectin for higher
intensities (ES of 0.74), but not for lower (ES of −1.14) with
no differences noted for changes in leptin, relative to ET.
Likewise, RT induced a greater ES for changes in IL-6
and CRP relative to ET, at higher (ES of 0.27 and 1.34,
respectively) and lower intensities (ES of 0.36 and 0.76,
Figure 6 Description of the pooled ES for treatment response and the range of CI for ES between intervention (versus diet with combination of
RT) methods for response related to changes in blood lipid profiles TC, HDL, LDL, and TG. Note that labeled groups go as follows: D indicating
diet-only, D(E) indicating diet with ET, D(R) indicating diet with RT, and D(E + R) indicating diet with ET and RT for the various intervention
methods within the comparisons.
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voring higher intensity RT at an ES of 0.47 for BM, of
0.30 for FM and 0.40 for FFM, respectively to any of the
ET protocols, ET and RT combination or lower intensity
RT. And favor higher intensity ET at an ES for 0.35 for
BM and 0.39 for FM but not for retention of FFM 0.13
relative to lower intensity ET. Where comparisons be-
tween exercise intensities within the ET and the RT pro-
tocols, indicated favor toward ET (ES of 0.66, 1.13, 0.61,
and 0.96 for TC, HDL, LDL, and TG respectively), and
RT (ES of 0.85, 0.86, and 0.60 for TC, LDL, and TG
respectively).
Discussion
Given that any change in behavior in highly sedentary
individuals who are overfat should result in an immedi-
ate effective means for altering both body composition
and health status. That occurs regardless of the methods
utilized for the adult who is overfat. And given that all
studies in publication indicate an ability to produce a
positive effect to both body composition and health
status. It should not be surprising to find ES across
studies that indicate and effective treatment regardlessof methodology utilized. Yet, while all treatment options
show a favor for effective treatment for inducing
changes in body mass. The effectiveness by which the
body composition measures changed was highly vari-
able based on the specific methodology being utilized.
Moreover, they varied widely in the effectiveness for
the biomarkers of health status of the adult who is
overfat, Table 2. Moreover, the analysis of ES pooled
across studies in aggregate indicate here is that what
has been the general classically recommend treatment
for overfatness, and associated diseases, may not actu-
ally be the most effective. Where the methodological,
and sociological, bias towards said programs may be the
inherent rationale for continued praise and high recom-
mendation to individuals who are overfat. And may
promote the reoccurring cycles of repetitive diets and
exercise programs for changes in body morphology and
health status [13,14,15,16].
As evident in the fact that classically recommended,
and routinely cited in popular press, lower fat diet was
less effective for changing any body compositional mea-
sures relative to the other dietary only options. With
the higher protein diets being more effective than the
Figure 7 Description of the pooled ES for treatment response and the range of CI for ES between intervention (versus diet alone or versus diet
with combination of ET, or versus diet with combination of RT) methods for response related to changes in Insulin. Note that the comparisons
are labeled as “treatment-to-comparison”, with D indicating diet-only, D(E) indicating diet with ET, D(R) indicating diet with RT, D(E + R) indicating
diet with ET and RT, ET indicating ET-only, and RT indicating RT-only for the various intervention methods within the comparisons.
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Therefore, should a diet-only intervention be recom-
mended, and in agreement with previous reviews on
the topic [61-64], a hypocaloric high-protein/low carbo-
hydrate diet appears to generate the greatest ES for
change relative to all hypocaloric, and low fat, diets.
This effectiveness appears within diet interventions that
utilized a level >1.5 g protein*kg−1body mass (>25% of
total kcal/d), within the hypocaloric diet with a CI for ES
induced always favoring the high protein diet, while not
with diets with lower protein, ~1.0 g of protein*kg−1BM
(<20% of total kcal/d), and higher carbohydrate (regardless
of glycemic load) threshold for ES induced a CI.95 that
crosses into the area of having no effect (i.e. ES ≤ 0) at
changing of body composition.
Further, the addition of exercise provided stimulus for
responses that are at least as effective as any diet-only
method for altering body composition, see Table 2 and
Figure 2. And analysis of effectiveness showed prefer-
ence of favor toward RT rather than the classically rec-
ommended ET at being more effective to elicit beneficialchanges. When combined with diet, exercise interven-
tions were more effective at inducing responses in body
compositional changes than either an exercise, or diet,
alone option for intervention. The effectiveness for exer-
cise becomes more pronounced with higher levels of in-
tensity of exercise regardless of the methodology
employed (i.e. ET, RT, or combination therein) within
the intervention protocol. Additionally, there is a clear
delineation between the modes of exercise used and the
effectiveness at inducing responses. While heavy recom-
mended by a number of organizations and through a
variety of position stands [17,55,65], or stated in previ-
ous reviews on the subject [4,7-10,12], as being more ef-
fective at inducing changes in body composition the use
of a ET alone, or in combination with RT, and in com-
bination with diet interventions were not more effect
than the combination of RT with diet, Figure 2.
Within this difference of effectiveness for treatment,
diet with RT was not only more effective at altering BM
in the most beneficial pattern (i.e. reduction of FM with
retention of FFM), without regard to level of training,
Figure 8 Description of the pooled ES for treatment response and the range of CI for ES between intervention (versus diet alone) methods for
response related to changes in Adiponectin, Leptin, CRP, TNF- α and IL-6. Note that labeled groups go as follows: D indicating diet-only, D(E)
indicating diet with ET, D(R) indicating diet with RT, and D(E + R) indicating diet with ET and RT for the various intervention methods within
the comparisons.
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exercise. And when employed at even lower levels of
stimulation (e.g., <70% 1RM, single set for at least 12
repetitions, use of pneumatic or selectorized machines,
and performance of circuit resistance training) RT pro-
vides responses that mimic the ES from ET, or the com-
bination to ET and RT. Where responses mirror each
other, whether or not diet is involved in the treatment.
And becomes more effective at higher levels of stimula-
tion RT (e.g., >75-80% 1RM for at least 3 sets with repe-
tition ranges of 5-to-10 with 60-to-90 second rest
intervals) at inducing changes in body composition that
leads to the reduction of BM and FM, while retaining
(and in some cases increases of ) FFM for the individual
who is overfat. Further, ET appeared to have its greatest
effect when either in an interval style of ET, or at higher
intensities of at ≥75% VO2max (or HRmax/peak), while not
at the traditionally recommended moderate (e.g., 55-75%
VO2max, or HRmax/peak) steady-state ET for response to
changes in BM and FM, but not for changes in FFM.There is also the classically held view of the relation-
ship between caloric imbalance and the altering body
composition for adults who are overfat. Where if the as-
sumption is correct, there should be a relationship of
equivalence in effectiveness for changing caloric balance
with body compositional changes between treatment
methods. However, based on analysis here, the effective-
ness for inducing changes in caloric imbalance does not
match the effectiveness to induce body compositional
changes for the adult that is overfat. This alternate
view to the equation indicates, as previously speculated
[19,27], that the issue of overfatness is one that is
highly complex. Where there a variety of intercon-
nected factors at play beyond the simplistic caloric bal-
ance issue relative to not only body composition but
also the alteration of health status for the adult who is
overfat. And hints at a possible problem for continually
linking these two factors in relationship to changes,
not only body compositional changes but also the
health status change. As there are number of problem
Figure 9 Description of the pooled ES for treatment response and the range of CI for ES between intervention (versus diet with combination of
ET) methods for response related to changes in Adiponectin, Leptin, CRP, TNF- α and IL-6. Note that labeled groups go as follows: D indicating
diet-only, D(E) indicating diet with ET, D(R) indicating diet with RT, and D(E + R) indicating diet with ET and RT for the various intervention
methods within the comparisons.
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hormonal functions related to energetic balance (i.e.
leptin, ghrelin) and tightly associated with metabolic
markers of exertional stress (i.e. AMPK) [5,12,66,67].
Along with the inherent problem related to measuring
the absolute of energetic imbalance that may be
incurred from any intervention. Principally that the in-
dicated energetic imbalances are an assumed difference
in energetic balance. As very few protocols directly
measure the imbalance and no study reviewed on the
topic directly measured the energetic shift from either
the exercise sessions, the recovery from said sessions.
With only a few indicated changes in resting metabolic
rate related to either the hypocaloric diet or exercise or
combination therein. Thus it becomes troubling that
such relationships are continually stated as an absolute
as opposed to the assumption that it appears to be.
Therefore, it may be more beneficial to discuss in-
tervention methods based on metabolic stress (anddemand) rather than on the energetic imbalance, based
on the assumed difference, for the adult who is overfat.
While changes to body composition appear to be key
in the reinforcement necessary for continual use of the
treatment protocols over long periods of time, providing
the cheerleader effect for continuation of an intervention.
The changes elicited in humoral factors (e.g., hormone/
cytokines, blood lipids and biomarkers of inflammation)
are necessary for improvement in health status that
many have previously discussed in a number of reviews
on this topic [18-21,26,31,32,34,42]. As one of the key
indicators for metabolic health issues for adults that are
overfat is high levels of circulating insulin, it would be
expected that an effective therapeutic treatment would
elicit reductions in fasting levels of insulin would indi-
cate improvements in metabolic and immune condi-
tions [19,26,28,31-34,42].
In such, there are patterns of responses indicating a
spectrum of effectiveness, within and across the various
Figure 10 Description of the pooled ES for treatment response and the range of CI for ES between intervention (versus diet with combination of
RT) methods for response related to changes in Adiponectin, Leptin, CRP, TNF- α and IL-6. Note that labeled groups go as follows: D indicating
diet-only, D(E) indicating diet with ET, D(R) indicating diet with RT, and D(E + R) indicating diet with ET and RT for the various intervention
methods within the comparisons.
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ercise. As indicated with inducing changes in fasting
levels of insulin, where dieting alone is shown to be
overall less effective than any of the exercise or diet in
combination with exercise modalities. Once again the high-
protein (regardless of carbohydrate modification) diet was
more effective than the simply having a hypocaloric, or the
traditional low fat, diet within the spectrum of diet options
examined, ES of 0.49. And is seen even more so when com-
bined with an exercise programs, ES of 0.77. Lending further
support to the evolving opinion regarding the employment
of higher protein diets for adults who are overfat.
Additionally, exercise was more effective at inducing
changes in fasting insulin levels than diet. And in con-
gruence with many of the position stands offered and
classically recommend [1,17,55], the use of ET (both
alone and in combination with diet or in conjunction of
diet and RT) was more effective than RT (either when
used alone or in combination with diet) for eliciting changes
in insulin. This difference in treatment effectiveness isreversed with incorporation of the high protein/low carbo-
hydrate diet with combination of exercise where RT is more
effective than ET, regardless of intensity (ES of 3.5). It should
also be noted that the combination of diet with RT was only
intervention that provided a pooled therapeutic ES that did
not elicit the possibility of no response (i.e. crosses a point
of ES = 0) from treatment relative to the control. And not
surprisingly, the use of higher-intensity exercise was more
effective than lower-intensity exercise without regard to diet
selection. While these findings support the use of ET within
treatment protocols, there is an indication that RT is a viable
option for the adult who is overfat and does not self-select
towards an ET mode of exercise [13,15,27,28]. Thus
given the findings here, utilizing RT can be a more ef-
fective treatment for reversing insulin resistance, as the
psychological adherence to the program may provide
additional reinforcement for continual use of exercise
within a treatment regimen. And when combined with
the combination of a high protein/low carbohydrate
diet, RT exercise (regardless of level of intensity) can
Clark Journal of Diabetes & Metabolic Disorders  (2015) 14:31 Page 23 of 28be significantly more effective than the standard ET
recommendations.
There is also a spectrum effectiveness to elicit re-
sponses in blood lipids form the various treatments indi-
cates trends in the data towards the use of exercise (ET,
RT or combination thereof ) either alone or in combin-
ation with diet for effectiveness of treatment over the
use of simple dietary interventions. In which all treat-
ments offer a small degree of effectiveness for altering
lipid profiles for the individual who is overfat. With the
combination of diet and exercise was more effective than
diet alone or exercise alone. And as indicated here, there
is a favor toward use of RT is seen with eliciting reduc-
tions of blood lipids levels, TC, LDL and TG, relative to
either dieting alone, or in combination of diet with ET.
Which lends further support toward using RT within the
treatment methods. As previously noted, this difference
in effectiveness becomes even more pronounced in favor
of the higher intensity exercise protocols (regardless of
using ET or RT).
This spectrum for a continuum of effectiveness con-
tinues as related to the levels of cytokines (e.g., TNF-α,
CRP, leptin and adiponectin) related to inflammation
and chronic immune response. Where any treatment is
able to produce an effective change that leads toward a
normal “healthy” range, thus leading to a reduced risk for
development of cardiovascular disease and improvements
in work capacity and overall health [18,26,32,34,42,68].
However, these responses were highly variable and most
of the indications for effectiveness, both as a therapeutic
effect and treatment effect, near that point of zero differ-
ence in effect (i.e. ES = 0). Most interesting were re-
sponses seen in changes to levels of CRP, found in
relation to diet alone and diet with RT. Where diet com-
bined with RT induced an almost equal level of effective-
ness to that of diet alone. With both indicated as being
less effective than the combination of diet with ET or the
combination of diet with ET and RT. Indicating a possible
metabolic difference between exercise modalities that might
induce the differential cardiovascular adaptations noted
following these distinct intervention protocols.
Moreover, there are differences in effectiveness noted
between RT and ET. This is seen regardless of being uti-
lized alone or with modification to diet, or based on the
intensities of training. Based on such stratification
there is an indication for the role of the metabolic de-
mand of treatment eliciting differential response to
cytokine and adipokine signals that alter whole body
metabolism. Where it appears that the better means
for prescription of exercise is at the higher levels of
training intensities. And when associated with the con-
cept of self-selection toward distinct exercise modes
leading to greater utilization [13,15,56], supports the in-
dication for practitioners to recommend and prescribethe use of RT within treatment options that have been
speculated about previously [28,47-50]. As incorporat-
ing RT may provide the metabolic stimulus to not only
the means for improvement of health status but as it
may be more readily self-selected lead to longer periods
of utilization such activities throughout one’s remaining
lifespan as been previously suggested [15,69]. Especially
if RT is prescribed at the higher levels of training inten-
sities than what has been previously recommended and
closer to what is traditionally utilized for hypertophica-
tion responses in lean and active individuals.
While one intention of the study here was to examine
the changes in anabolic hormones that have shown re-
duced levels with overfatness (e.g., testosterone (T) and
growth hormone (GH)) in particular relative to the thera-
peutic interventions of diet, exercise or combination of
diet and exercise. There were too few studies that looked
at these changes in relation to the treatments that were
used, that did not involve a pharmaceutical intervention.
From the few studies that examined this change, the rela-
tive changes in absolute values note an increase in testos-
terone and growth hormone that seem to not be related
to the intervention used, but instead changes in FM fol-
lowing treatment. While a number of studies have exam-
ined the issue in responses acutely either to exercise
relative to differences between the normal fat control and
the overfat population, or in relation to a pharmaceutical
treatment option without use of exercise. Given the
current opinions [36,70-72] regarding the role of such
hormones in relation to body composition and disease it
seems that studying such changes may prove to be a very
fruitful avenue for future research in the various interven-
tion programs. Especially given the previously noted
changes in GH from hypocaloric diets and within various
exercise treatments utilized [73,74]. Which is matched
with the changes in levels of T, binding proteins and per-
ipheral receptors for T that are associated with exercise, in
particular RT in a fasting state (which should relate well
with a hypocaloric model), and may mirror the hormone
replacement therapy treatment application for some indi-
viduals with this population [45,46,132,75-78]. However,
there is limited analysis to speculate either to the extent,
beyond expected changes toward normal levels, or time
frame for changes within anabolic hormones for adults
who are overfat. But given the compatibility of immuno-
logical and metabolic profiles between the overfat and the
elderly populations, it can be speculated that use of exer-
cise, in particular RT should mimic what has been shown
with elderly populations [79-82].
Conclusions
Analysis of effectiveness of responses both within and
between interventions differences for treatment options
modalities (e.g., diet, exercise, or combination therein)
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versus low intensity, high protein/low carbohydrate di-
ets) indicate a continuum of effectiveness. Most import-
antly is that protocols utilizing exercise were more effective
than those that employed just a hypocaloric diet. With the
combination of diet with exercise (especially RT) being
more effective than diet or diet with ET in reduction of
body mass and fat mass while retaining of FFM following
treatment. And are at least as effective for changing hormo-
nal levels and blood lipid profiles. Also, while popular ideas
suggest the necessity for acute energetic imbalance, there
appears to be no relationship between any treatments ef-
fectiveness for inducing acute changes in energetic balance
with the effectiveness for induced responses to body com-
position or biomarkers of health from said treatment pro-
gram. All of which reinforces the idea of a more complex
network of factors that influence overall body composition
and health issues for the adult who is overfat, and further
stresses the idea to focus treatment on generating a meta-
bolic stress to induce chronic endocrinological (and cyto-
kine) changes as opposed to the focus on the kcal/d (kJ/d)
ratios of intake to expenditure.
Further, based on ES for responses to RT (in combin-
ation with diet, or with diet and ET), one would be able
to expect that at the very least 55% of any population of
overfat adults should have beneficial responses in all
body compositional measures from the incorporation of
RT into a treatment play, along with an even greater
percentage having a favorable response to altering fast-
ing levels of insulin, total cholesterol, low-density lipo-
proteins and triglycerides. Additionally, when exercise is
utilized at appropriate intensities (i.e. higher levels) both
ET and RT provides an effective stimulus to alter TNF-α,
CRP, leptin and adiponectin levels that all indicate a re-
duction in the risk for cardiovascular disease and im-
proved metabolic flexibility for the adult who is overfat.
With RT producing a greater level of effectiveness for
altering these measures, especially when RT is progres-
sive and periodized with a training volume of 2-to-3
sets at 6-to-10 reps with an intensity of ≥75% 1RM and
a rest interval of 60–90 seconds, and utilizes whole
body (and free-weight) exercises. And thus indicates
that RT should be more readily recommended as an ap-
propriate treatment option to adults who are overfat
than what has been recommended currently.
Yet, however the effectiveness of this combination of
diet and RT might be for inducing changes, the concept
of self-selection of exercise patterns means that some
adults who are overfat may select toward protocols of
ET for exercise. For those who self-select toward ET, it
appears that ET is more effective when performed at
high intensity (e.g., ≥70% VO2max, or HRmax) steady-
state method or as an interval training style (based on
ES calculated gives an expectations of at least 40% of thepopulation showing beneficial responses to intervention).
Likewise, some may select away from exercise altogether,
which based on overall effectiveness should be discour-
aged but if utilized as a stand alone intervention, diets
can be effective if hypocaloric and comprised of a higher
percentage of total caloric intake from protein, with an
expectation for at least 55% of the population showing a
beneficial response from the intervention.
Lastly, there needs to be further examination of findings
noted here. First, related to the ongoing understanding of
the anabolic dysregulation that accompanies the situation
of being overfat. In this light there is a need to examine
the relationship of changes in said hormones based on
intervention within populations of individuals who are
overfat. Not with simply acute comparison to lean active
population, but within the concept of altering levels of
anabolic hormones, responses at peripheral tissues and
the relative timeframe for seeing such hormonal responses
based on the various interventions utilized. And how the
impact of periodization and concurrent exercise exposure
has on these responses. Second, related to the issues of
differential response between genders to identify if there
may be a more beneficial response for males versus those
for females, and vice versa. Third, based on the current
understanding of application of exercise modalities if there
are differential responses to programs based on location
for intervention and professional associated with oversee-
ing intervention (e.g., in hospital versus out-patient phys-
ical therapy clinic versus community health center/
gymnasium or for-profit health center/gymnasium). Add-
itionally, and as noted earlier, there needs to be an evalu-
ation of programs and protocols readily available to the
populous or utilized within studies for this population.
Most exercise programs seem to be highly elaborate for
the sake of complexity. In what appears as an effort of
marketing the program as being different, as opposed to
being elaborate for the sake of progressive periodization.
Where the elaboration for periodization of exercise is
meant to provide stimulus for continual adaptations
within the exerciser. Finally, most programs that have
been established based on the idea of energetic imbal-
ance need to be careful with establishing such an idea,
as the energetic imbalance is based on an assumption
that might not be held in all cases. As changes to not
only body composition but also health status comes
from manipulation of highly elaborate network of fac-
tors that interact, compliment and confound the impact
of each other for the adult who is overfat leading to not
only body compositional changes, but reversal of the
deleterious health outcome of being overfat.
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